According to KOBAYASHI Pharmaceutical's latest financial reports the company has ยฃ0.32 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | ยฃ0.44 B | -32.68% |
2022-12-31 | ยฃ0.66 B | -5.94% |
2021-12-31 | ยฃ0.70 B | 4.61% |
2020-12-31 | ยฃ0.67 B | 5.81% |
2019-12-31 | ยฃ0.63 B | 7.34% |
2018-12-31 | ยฃ0.59 B | 22.77% |
2017-12-31 | ยฃ0.48 B | |
2016-03-31 | ยฃ0.40 B | 15.25% |
2015-03-31 | ยฃ0.35 B | 9.38% |
2014-03-31 | ยฃ0.32 B | -2% |
2013-03-31 | ยฃ0.33 B | -18.65% |
2012-03-31 | ยฃ0.40 B | 26.34% |
2011-03-31 | ยฃ0.32 B | 6.97% |
2010-03-31 | ยฃ0.30 B | 48.08% |
2009-03-31 | ยฃ0.20 B | 75.11% |
2008-03-31 | ยฃ0.11 B | 22.4% |
2007-03-31 | ยฃ94.69 M | -25.29% |
2006-03-31 | ยฃ0.12 B | 28.08% |
2005-03-31 | ยฃ98.96 M |